Drug
Strontium Ranelate
Strontium Ranelate is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_4
4
80%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 4Post-market surveillance
4(80.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 44 (80.0%)
N/A1 (20.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
unknownphase_4
Role of Strontium Ranelate in Proximal Femur Fragility Fractures.
NCT05712616
completednot_applicable
Strontium Ranelate and KOA
NCT03937518
completedphase_4
Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
NCT01544894
completedphase_4
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
NCT00479037
completedphase_4
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
NCT00239629
Clinical Trials (5)
Showing 5 of 5 trials
NCT05712616Phase 4
Role of Strontium Ranelate in Proximal Femur Fragility Fractures.
NCT03937518Not Applicable
Strontium Ranelate and KOA
NCT01544894Phase 4
Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
NCT00479037Phase 4
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
NCT00239629Phase 4
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5